{
  "id": 6565106,
  "title": "Insight Innovation: Die riskante Wette auf den ersten Impfstoff gegen Krebs",
  "url": "https://urgent.news/2026/09/10/insight-innovation-die-riskante-wette-auf-den-ersten-impfstoff-gegen",
  "topic": "business",
  "section": "Business",
  "published": "2026-09-10T08:08:00.000Z",
  "source": {
    "name": "Handelsblatt",
    "slug": "handelsblatt",
    "url": "https://www.handelsblatt.com/technik/forschung-innovation/mrna-kann-krebs-bald-mit-derselben-technologie-bekaempft-werden-wie-corona/100248932.html"
  },
  "original_language": "de",
  "account": "Munich became the site of Moderna's first major breakthrough in drug development in 2021. Amid the raging Covid-19 pandemic, Moderna's CEO, Stéphane Bancel, announced strong test data for a Covid-19 vaccine. Five years later, Moderna is targeting its next medical breakthrough, this time against cancer. This is the most risky and expensive bet for the US biotech company. As of last Wednesday, the pharmaceutical world was skeptical about the project. Then, Moderna announced surprisingly positive test results for an innovative skin cancer vaccine. The company is developing the drug in partnership with US pharmaceutical giant Merck & Co. It marks the first use of messenger RNA (mRNA) technology to treat cancer in a large, approval-relevant study. The drug could hit the market as early as 2027. Researchers and analysts speak of a scientific breakthrough. Wall Street analysts expect billions in revenue, even tech investors are impressed. Could the same principle used to combat coronavirus be applied to fight skin cancer?",
  "summary": "Hautkrebs könnte bald mit demselben Prinzip bekämpft werden, mit dem schon das Coronavirus gebändigt wurde. Moderna und Merck melden Erfolge mit einem mRNA-Impfstoff. Doch es gibt Hürden.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Handelsblatt",
        "title": "Insight Innovation: Die riskante Wette auf den ersten Impfstoff gegen Krebs",
        "url": "https://urgent.news/2026/09/08/insight-innovation-die-riskante-wette-auf-den-ersten-impfstoff-gegen",
        "published": "2026-09-08T07:38:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}